Literature DB >> 9740130

Characterization of an anti-RNA recombinant autoantibody fragment (scFv) isolated from a phage display library and detailed analysis of its binding site on U1 snRNA.

S W Teunissen1, M H Stassen, G J Pruijn, W J van Venrooij, R M Hoet.   

Abstract

This is the first study in which the complex of a monoclonal autoantibody fragment and its target, stem loop II of U1 snRNA, was investigated with enzymatic and chemical probing. A phage display antibody library derived from bone marrow cells of an SLE patient was used for selection of scFvs specific for stem loop II. The scFv specificity was tested by RNA immunoprecipitation and nitrocellulose filter binding competition experiments. Immunofluorescence data and immunoprecipitation of U1 snRNPs containing U1A protein, pointed to an scFv binding site different from the U1A binding site. The scFv binding site on stem loop II was determined by footprinting experiments using RNase A, RNase V1, and hydroxyl radicals. The results show that the binding site covers three sequence elements on the RNA, one on the 5' strand of the stem and two on the 3' strand. Hypersensitivity of three loop nucleotides suggests a conformational change of the RNA upon antibody binding. A three-dimensional representation of stem loop II reveals a juxtapositioning of the three protected regions on one side of the helix, spanning approximately one helical turn. The location of the scFv binding site on stem loop II is in full agreement with the finding that both the U1A protein and the scFv are able to bind stem loop II simultaneously. As a consequence, this recombinant monoclonal anti-U1 snRNA scFv might be very useful in studies on U1 snRNPs and its involvement in cellular processes like splicing.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9740130      PMCID: PMC1369687          DOI: 10.1017/s1355838298980633

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  25 in total

1.  In vitro selection of RNA epitopes using autoimmune patient serum.

Authors:  D E Tsai; J D Keene
Journal:  J Immunol       Date:  1993-02-01       Impact factor: 5.422

2.  Anti-(U1) small nuclear RNA antibodies in anti-small nuclear ribonucleoprotein sera from patients with connective tissue diseases.

Authors:  W J van Venrooij; R Hoet; J Castrop; B Hageman; I W Mattaj; L B van de Putte
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

3.  The use of chemical nucleases to analyze RNA-protein interactions. The TFIIIA-5 S rRNA complex.

Authors:  P Darsillo; P W Huber
Journal:  J Biol Chem       Date:  1991-11-05       Impact factor: 5.157

4.  Epitope regions on U1 small nuclear RNA recognized by anti-U1RNA-specific autoantibodies.

Authors:  R M Hoet; P De Weerd; J K Gunnewiek; I Koornneef; W J Van Venrooij
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

5.  The human U1 snRNP-specific U1A protein inhibits polyadenylation of its own pre-mRNA.

Authors:  W C Boelens; E J Jansen; W J van Venrooij; R Stripecke; I W Mattaj; S I Gunderson
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

6.  Purification and characterization of human autoantibodies directed to specific regions on U1RNA; recognition of native U1RNP complexes.

Authors:  R M Hoet; B Kastner; R Lührmann; W J van Venrooij
Journal:  Nucleic Acids Res       Date:  1993-11-11       Impact factor: 16.971

7.  Solution structure of human U1 snRNA. Derivation of a possible three-dimensional model.

Authors:  A Krol; E Westhof; M Bach; R Lührmann; J P Ebel; P Carbon
Journal:  Nucleic Acids Res       Date:  1990-07-11       Impact factor: 16.971

8.  Identification of molecular contacts between the U1 A small nuclear ribonucleoprotein and U1 RNA.

Authors:  T H Jessen; C Oubridge; C H Teo; C Pritchard; K Nagai
Journal:  EMBO J       Date:  1991-11       Impact factor: 11.598

9.  Transcription-dependent colocalization of the U1, U2, U4/U6, and U5 snRNPs in coiled bodies.

Authors:  M Carmo-Fonseca; R Pepperkok; M T Carvalho; A I Lamond
Journal:  J Cell Biol       Date:  1992-04       Impact factor: 10.539

10.  Nucleoplasmic organization of small nuclear ribonucleoproteins in cultured human cells.

Authors:  A G Matera; D C Ward
Journal:  J Cell Biol       Date:  1993-05       Impact factor: 10.539

View more
  4 in total

1.  Preparation of single chain variable fragment of MG(7) mAb by phage display technology.

Authors:  Z C Yu; J Ding; Y Z Nie; D M Fan; X Y Zhang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

2.  Inosine and N1-methylinosine within a synthetic oligomer mimicking the anticodon loop of human tRNA(Ala) are major epitopes for anti-PL-12 myositis autoantibodies.

Authors:  H F Becker; Y Corda; M B Mathews; J L Fourrey; H Grosjean
Journal:  RNA       Date:  1999-07       Impact factor: 4.942

3.  A fast and efficient procedure to produce scFvs specific for large macromolecular complexes.

Authors:  Si Wu; Ailong Ke; Jennifer A Doudna
Journal:  J Immunol Methods       Date:  2006-11-03       Impact factor: 2.303

4.  Synthetic antibodies for specific recognition and crystallization of structured RNA.

Authors:  Jing-Dong Ye; Valentina Tereshko; John K Frederiksen; Akiko Koide; Frederic A Fellouse; Sachdev S Sidhu; Shohei Koide; Anthony A Kossiakoff; Joseph A Piccirilli
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-27       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.